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Severe deep white matter lesions and outcome in elderly
patients with major depressive disorder: follow up study
John O’Brien, David Ames, Edmond Chiu, Isaac Schweitzer, Patricia Desmond, Brian Tress
Abstract
Objective To determine the difference in outcome
among elderly people with major depression who do
and do not have severe white matter lesions on
magnetic resonance imaging.
Design Follow up study.
Setting Two psychiatric and two general hospitals in
Melbourne, Australia.
Subjects 60 depressed subjects aged over 55 referred
to hospital psychiatric services with major depressive
disorder meeting American Psychiatric Association
(DSM›IIIR) criteria.
Main outcome measure Proportion with good
outcome as determined by full recovery from initial
illness and no evidence of depressive relapse or
cognitive decline during follow up among those with
and without lesions.
Results Mean (SD) follow up was 31.9 (9.9) months.
Survival analysis showed a significant effect of severe
lesions on time to poor outcome (P = 0.04), with
median survival 136 days in those with severe lesions
compared with 315 days in those without.
Conclusion Severe white matter change on magnetic
resonance imaging is associated with poor outcome in
elderly depressed subjects.
Introduction
Major depressive disorder1 in older people often has a
poor prognosis.2 Cerebral organic factors may predict
poor outcome.2 3 Recent studies of the brains of elderly
depressed patients have reported an excess of deep
white matter lesions (but not periventricular lesions)
on magnetic resonance imaging. Mild and moderate
white matter lesions are common in healthy elderly
people and of uncertain significance. However, severe
changes are not part of normal ageing, although they
are often seen in elderly depressed subjects.4 Such
severe white matter lesions may predispose to the
onset of first depression in some elderly people4 and
have been reported to be associated with poor
response to initial treatment.5 6 It is not known,
however, whether white matter lesions have any
influence on long term outcome in major depressive
disorder. We report a follow up study of 54 elderly sub›
jects with major depressive disorder, all of whom had
magnetic resonance imaging at baseline to determine
the presence and severity of deep white matter and
periventricular lesions.
Subjects and methods
A more detailed account of subject selection and scan›
ning procedure has been published.4 In brief, 60
consecutive patients aged over 55 who met the
Diagnostic and Statistical Manual of Mental Disorders
(DSM›IIIR) criteria for major depressive disorder were
recruited from two general and two old age psychiatric
units in Melbourne over 18 months in 1992›3. All con›
sented to magnetic resonance imaging and had a full
psychiatric assessment including physical examination
and screening blood tests (routine haematology and
biochemical analyses including tests of thyroid
function). Severity of depression was assessed with the
Hamilton depression rating scale7 and cognitive
function with the Cambridge cognitive examination,8
which includes the mini›mental state examination.
Subjects were excluded if they had a history of stroke,
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transient ischaemic attacks, epilepsy, Parkinson’s
disease, substance misuse, untreated hypothyroidism,
cancer, insulin dependent diabetes, or other life threat›
ening illness.
Magnetic resonance imaging
A 0.3 Tesla magnet (Fonar, Melville, New York) was
used to obtain double spin echo T2 weighted (30/85/
2000 TE/TE/TR) images. We took 5 mm axial slices
with a 2.5 mm interslice interval and 5.1 mm coronal
slices with a 0.5 mm interslice interval. Pixel size was
0.94 × 1.25 mm. The severity of deep white matter and
periventricular lesions was rated independently by two
experienced neuroradiologists (PD and BT) blind to
clinical diagnosis. Both coronal and axial images were
used to rate lesions on a standard 0›3 scale.9 Inter›rater
reliability was assessed by using weighted ê and was
0.81 for deep white matter lesions and 0.75 for
periventricular lesions.4 When the raters disagreed the
rating made by PD was used for analysis.
Follow up
Subjects were followed up by experienced raters blind
to the initial findings of magnetic resonance imaging.
The dates of follow up varied according to clinical cir›
cumstances, but the aim was to achieve annual follow
up for three years where possible. Severity of
depression and cognitive function were assessed by the
same methods as at baseline, and the raters also inter›
viewed a carer and obtained history of intercurrent
psychiatric illness and treatment. Initial and follow up
diagnoses were made according to standard criteria for
psychiatric disorder.1 Case notes were searched to
determine the date of depressive relapse, return to
depressive invalidism, or development of dementia
where appropriate. Outcome for all subjects at their
last follow up, blind to magnetic resonance imaging,
was rated by DA using all available data as (a) continu›
ously free from depression after initial recovery; (b)
currently free from depression after intervening
relapse of major depressive disorder; (c) “depressive
invalidism”—disabling depressive symptoms not suffi›
cient to meet criteria for major depressive disorder; (d)
currently suffering from a relapse of major depressive
disorder; (e) continuously ill with major depressive dis›
order from index episode; (f ) demented; or (g) dead.
For subjects who had died the date of death was
entered as the date of final follow up.
Analysis of data
Subjects were divided into two groups: those with
severe lesions and those with no, mild, or moderate
lesions. Only severe lesions differentiate those with
depression from healthy elderly people, and we
hypothesised that such lesions may represent patho›
logical brain change (as opposed to normal age related
changes) and so be important in determining
outcome. Data were analysed by first categorising
patients in group (a) as having a good outcome and
those in the other groups as having a bad outcome in
accordance with established practice.2 Since some
patients who have had a single relapse but made good
recovery from this might also be considered as having
a good outcome we reanalysed data including subjects
who were well at follow up (groups a and b) as having
good outcomes. We also conducted an analysis in
which we included all subjects who had remained free
from major depression or depressive invalidism until
death as having a good outcome.
A Kaplan›Meier survival analysis was performed to
take account of the variable length of follow up, as
some subjects were at higher risk of relapse simply
because they had been followed up for a longer time.
Differences in survival rates between severe and
non›severe lesion groups were determined by the log
rank test. Survival time was assessed as time taken from
initial recovery date until date of first relapse or death,
or, for patients who remained well, until date of final
follow up. Those who never recovered fully were
deemed to have had a survival time of 0 days.
Results
Mean age of the 60 subjects at entry to the study was
71.2 years (SD 7.9) and 18 were men. Table 1 shows the
presence and severity of lesions. Fifty four subjects
were followed for between 2 and 48 months (mean
31.9 (SD 9.9) months). Six subjects refused any follow
up or were lost to follow up. One subject died after two
months, eight subjects were followed for 12›24 months,
20 for 24›36 months, and 25 for 36 months or more.
No association was found between outcome and peri›
ventricular lesions. Table 2 shows the outcome at 32
months and the numbers with severe deep white
matter lesions.
Subjects with severe (grade 3) deep white matter
lesions had a significantly worse outcome than others
and none remained continuously well (Fisher’s exact
probability test P = 0.048). The effect of severe lesions
was significant for all three definitions of good
outcome. When the eight subjects who were well at fol›
low up after a relapse of major depressive disorder
were reclassified as having a good outcome only one of
the 13 subjects with severe deep white matter lesions
(88%) had a good outcome compared with 18 of 41
(44%) who did not have severe lesions (P = 0.02). Simi›
larly, when the five subjects who died after remaining
Table 1 Presence and severity of brain lesions at start of follow
up in 60 patients with major depressive disorder
Severity of lesions
No with deep white
matter lesions
No with periventricular
lesions
None 9 19
Mild 20 11
Moderate 15 13
Severe 16 17
Table 2 Outcome after 32 months among 54 patients with major depressive disorder
according to presence of severe deep white matter lesions on magnetic resonance
imaging
Outcome
Severe white
matter lesions
Without severe
white matter
lesions
No (%)
95% CI
(%) No (%)
95% CI
(%)
Continuously well* 0 (0) 0 to 21 11 (27) 14 to 43
Recovered, one relapse and recovered 1 (8) 0 to 36 7 (17) 7 to 32
Continuously ill or recovered, relapsed and then remained ill 6 (46) 19 to 75 14 (34) 20 to 51
Demented/died 6 (46) 19 to 75 9 (22) 11 to 38
Total 13 41
*Fisher’s exact probability test (two tailed) for comparison of good (continuously well) v bad outcomes
(other categories) P = 0.048.
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well from initial recovery were combined with the 11
who had been continuously well the association of
severe lesions with bad outcome had a P value of 0.05.
In order to determine whether some factor related
to the lesions may have affected outcome we
performed analyses taking into account the potential
confounding variables of age, sex, length of time with
major depressive disorder before initial assessment,
severity of depression, age at onset of first episode,
diastolic blood pressure, and presence of cardiovas›
cular risk factors.4 None of these variables was
significantly associated with outcome. There was no
association between periventricular lesions and out›
come in any analysis.
Survival analysis confirmed the effects of severe
lesions on poor outcome (figure). Survival functions
for the severe and non›severe lesion groups were
significantly different (Log rank test statistic 3.63,
df = 1, P = 0.04). Median survival time for the 13
subjects with lesions was 136 days (95% confidence
interval 0 to 309) compared with 315 days (0 to 813)
for those without lesions.
Discussion
In this two year follow up of a cohort of elderly patients
with major depression and no overt cerebrovascular
disease, severe deep white matter lesions predicted
poor outcome. The result was not accounted for by
confounding factors, although larger studies are
needed to confirm a specific association between
severe lesions and poor outcome.
We do not believe that the missing subjects have
unduly biased the outcome as they were similar to the
others in all relevant respects. Even if all six were allo›
cated to the bad outcome group the significant associ›
ation between severe lesions and bad outcome would
remain. By traditional strict outcome criteria 80% of
the sample did badly. However, the subjects were
elderly and had required hospital treatment for
depression and their outcomes are not inconsistent
with earlier work on similar populations.2 The
association remained when less stringent definitions of
bad outcome were used. Periventricular lesions, which
have been shown to be common in Alzheimer’s
disease, had no effect on outcome.
Our results and previous work show that some eld›
erly patients with major depressive disorder have
evidence of damage to deep white matter structures
which may have a role in the initiation, maintenance,
and outcome of their condition. Limited neuropatho›
logical study of the structural basis of such white mat›
ter lesions in non›depressed subjects has shown severe
lesions to be associated with demyelination, perivascu›
lar change, and arteriosclerosis.10 11 More studies are
now needed on the neuropathological and neuro›
chemical correlates of such lesions in depressed
subjects. Such information may inform new treatments
for this group of patients, who currently have a poor
prognosis. In the interim, it seems prudent to take
account of the presence of severe white matter lesions
when considering the frequency of clinical monitoring
and the need for prophylactic antidepressants.
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Survival analysis showing effect of white matter lesions on time to
depressive relapse. Survival rates are significantly different between
groups (P = 0.04)
Key messages
x Severe deep white matter lesions on magnetic resonance imaging
are common in elderly patients with depression
x Patients with these lesions are at greater risk of poor long term
outcome (chronicity and relapse) than those without lesions
x The neuropathogical and neurochemical correlates of these white
matter changes need investigation
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